Ours Privacy announced on December 11, 2025 the launch of a Next-Generation Analytics Suite expanding its HIPAA-compliant CDP platform. The four core new capabilities:
- Multi-Touch Attribution (MTA): Models channel contributions to patient conversions within HIPAA constraints
- Web Analytics: Real-time traffic and engagement monitoring built for modern privacy requirements
- Session Replay: User interaction visualization without exposing protected health information
- User Funnels and Flows: Drop-off analysis and patient journey optimization
The platform has evolved from its original pixel-replacement and CDP offering to a full-stack healthcare marketing platform covering consent management, audience building, session replay, analytics, embedded maps and videos, integrations with Google Ads, Meta Ads, CRM systems, scheduling platforms, and data warehouses.
Quote (Adam Putterman, co-founder): "Healthcare teams need clarity, but they also need compliance. Our analytics suite is designed to empower growth while keeping privacy at the center."
Market context: Healthcare organizations face increased privacy litigation and stricter federal guidance restricting traditional tools including third-party cookies and legacy analytics platforms.
This source provides vendor-originating evidence that Ours Privacy has expanded beyond its initial HIPAA pixel-replacement scope to a broader CDP platform. Combined with the existing Rock Health investor source, this raises the vendor.ours-privacy candidate body's coverage of current capabilities, though the vendor-origin of both sources keeps the confidence ceiling below the 0.80 auto-apply threshold.